This week, hosts Mark Masselli and Margaret Flinter speak with Dr. Naor Bar-Zeev, Deputy Director of the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health. He examines the scientific guidelines governing COVID-19 vaccine phase 3 clinical trials, including a broad demographic representation to ensure vaccine safety across multiple populations, and the need to address vaccine hesitancy as well as the global supply chain needed to distribute billions of doses.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
ENCORE - Originally aired November 7, 2024 There’s a lot of attention right now around…
Originally broadcast May 15, 2025 Millions are still living with the effects of Long COVID…
It’s a troubling situation: Nearly one in three high school students report persistent feelings of…
Description: Dr. Igor Koralnik, the co-director of Northwestern Medicine’s Comprehensive COVID-19 Center, is one of…
Dr. Leana Wen, a health news commentator for The Washington Post and CNN, is known…
Very early this morning the U.S. House passed a bill that would result in more…